Navigation Links
HeartSine Technologies Honored With Belfast Ambassador Award at Belfast Business Top 50 Event
Date:10/11/2010

STORMONT, BELFAST, Northern Ireland, Oct. 11 /PRNewswire/ -- HeartSine Technologies, Inc. was honored with the Belfast Ambassador Award at the sixth annual Belfast Business Top 50 event in Stormont, Belfast. The award was presented to the company by the Belfast Media Group for pioneering business in developing areas of Belfast, Ireland.

HeartSine CEO Greg Cash, who accepted the award at the Long Gallery in Stormont on behalf of HeartSine, said, "We are honored to be singled out for the Belfast Ambassador Award.  HeartSine has a rich history of innovation and public awareness, especially in the area of Sudden Cardiac Arrest (SCA). We are proud of the work we've done in Northern Ireland, and all around the world."

Cash took the opportunity to share information about SCA and encouraged the attendees to consider starting a Public Access Defibrillator program in their respective organizations. SCA does not discriminate. It can happen anywhere, to anyone, at any time and accounts for an estimated 425,000 deaths in the United States each year, more than the total death rate for breast cancer, lung cancer, and HIV/AIDS combined. The annual mortality rate from SCA throughout Europe and North America exceeds one million. When a defibrillator is used within the first three to five minutes after the onset of SCA, the victim's chance of survival improves 40 to 75 percent.

The 50 companies recognized at the ceremony represented a diverse range of business leaders and entrepreneurs from the Belfast area. Each has worked tirelessly in their individual fields to progress and develop their businesses, despite the economic challenges.

HeartSine's European headquarters is located at 203 Airport Road West, Belfast, Northern Ireland BT3 9ED. For more information, contact +44 (0) 28 9093 9400, info@heartsine.co.uk.

About HeartSine Technologies (www.heartsine.com)

A world leader in personal and public access defibrillators, HeartSine's mission is to advance the deployment of lifesaving defibrillation therapy in non-traditional areas of care through the development of proprietary technologies and quality products. Its HeartSine® samaritan® PAD Public Access Defibrillator is especially designed for rescuers of all skill levels to administer lifesaving treatment for Sudden Cardiac Arrest. Sophisticated and lightweight, it's ideal for sports facilities, schools, churches and businesses. Additional information:  info@heartsine.com; (866) 478-7463, ext. 112.


'/>"/>
SOURCE HeartSine Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. HeartSine Technologies Recognized as an Index 30 Company at New York-New Belfast Conference
2. HeartSine Technologies Supports Living for Zachary Benefit Golf Tournament
3. HeartSine Technologies Supports Run For Sarah Benefit Event
4. Motorcyclist Volunteers Come to the Rescue With HeartSine AEDs
5. HeartSine and Your Safety Company to Donate a Portion of Sales Proceeds to Sudden Cardiac Arrest Foundation
6. Industry Leader BioStorage Technologies Broadens Sample Management Operations to Include Laboratory Sample Preparation Services
7. DiFUSION Technologies Completes Successful Antimicrobial Implant Animal Trial
8. IDEV Technologies Completes $46 Million Preferred Stock Financing With Piper Jaffray and Additional Strategic Investor
9. DiFUSION Technologies Adds Accomplished Senior Management Team
10. DiFUSION Technologies Receives 510(k) Clearance of Xiphos™ Interbody Implants for Spinal Fusion
11. medSage Technologies Introduces Revolutionary Universal CPAP Monitor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... SAN FRANCISCO , March 27, 2017  Twist ... high-quality DNA synthesis, today announced that it raised an ... a total of $166 million. "It ... as we expand our reach and continue to deliver ... in multiple market segments," commented Emily M. Leproust, Ph.D., ...
(Date:3/27/2017)...   Genprex, Inc. , a privately held, clinical-stage biopharmaceutical company ... the Company,s Chief Operating Officer, is scheduled to present a corporate ... 5th Annual Cancer BioPartnering & Investment Forum: Tuesday, March 28, 2017 ... ... 24th Annual Future Leaders in Biotech Industry – Friday, April 7, ...
(Date:3/24/2017)... PORTLAND, Oregon and PUNE, India , March 24, 2017 ... in 2015, and is estimated to reach $2,614 million by 2022, Globally, registering a ... expected to generate the highest revenue, and is projected to dominate the market during ... ... Allied Market Research Logo ...
Breaking Medicine Technology:
(Date:3/27/2017)... ... ... A study by the founder of the Buckingham Center for Facial Plastic ... published in the American Journal of Cosmetic Surgery. “The Effects of an Antistick Phospholipid ... the use of Electro Lube during the facelift procedure. The journal, a publication of ...
(Date:3/27/2017)... Niles, IL (PRWEB) , ... March 27, 2017 ... ... testing systems, recently received the CE Certificate of Conformity for the Smart System® ... meet or exceed the highest industry standards and specifications such as ANSI, ISO ...
(Date:3/27/2017)... ... March 27, 2017 , ... Metabolism ... program at Women’s Excellence will help patients lose weight and keep it off. ... The specialists at Women's Excellence will measure BMI, body fat composition, and Calcium ...
(Date:3/27/2017)... ... March 27, 2017 , ... The ... supply chain professionals, will hold their first Northeast Regional AHVAP Meeting. For 2017, ... , “Increasingly, supply chain and value analysis professionals have a ‘seat at the ...
(Date:3/27/2017)... ... March 27, 2017 , ... Sodium determination is ... complicated and require expert user knowledge. In a live webinar on April 11th ... simplified, yet highly accurate, determination of sodium. , It has long been known ...
Breaking Medicine News(10 mins):